The review group have begun their work and will meet for the first time together on 6 October. I will publish the report and announce actions arising from the review group’s recommendations early in the new year. Taken together, the new treatment fund and the review of the IPFR process will lead to a real change in how patients in Wales gain access to innovative medicines, and I expect a real improvement in the service that patients rightly expect from the NHS here in Wales.